Biocon Limited has informed the Exchange regarding a press release dated September 06, 2023, titled "Biocon Biologics Continues to Expand Global Footprint, Completes Integration of Viatris Biosimilars Business In North America, Ahead of Schedule".
Biocon Limited has informed the Exchange regarding a press release dated September 06, 2023, titled "Biocon Biologics Continues to Expand Global Footprint, Completes Integration of Viatris Biosimilars Business In North America, Ahead of Schedule".